Collaboration

P4O2 is a public private initiative. People with varying risk of developing lung disease, research institutes, societies, and companies are involved.

By bringing together these expertises in the lung field, we aim to accelerate development of products for early detection and personalized treatment of lung diseases. The well defined patient cohorts, in addition to a cohort of persons without lung diseases (but part of them at high risk) and the development of innovative laboratory models greatly contribute to this accelartion. Activities in P4O2 are for example phenotyping and endotyping of disease, finding biomarkers for early and progressing lung disease in patient samples and in patient-derived cell models, testing new devices for diagnosis of lung disease in the cohorts and small intervention trials. We invite you to collaborate in the consortium in order to achieve those goals together. Please contact p4o2@amsterdamumc.nl for more information.

P4O2 is a program of the NPL, which is an initiative of the NRS, supported by the ERS, Dutch Lung Foundation, NVALT, LAN, CAHAG, and patients with lung disease. An overview of organizations that are part of the consortium can be found below.

Nationaal Programma Longonderzoek
Initiative of the NRS, Lung Foundation Netherlands, LAN
Supportred by NVALT, CAHAG, ERS

Collaboration

Partners

P4O2 is supported by